CGRRF1 and breast carcinoma: To identify the relevant target(s) of CGRRF1 in MDA-MB-231 breast cancer xenografts, the lysates of five tumors from each group were subjected to reverse phase protein array (RPPA) analysis which measured the expression of 236 proteins in triplicate from each tumor.